. she suffered a "third brain bleed" and was pronounced brain dead on monday.
.
., an emerita professor in the department of food science & technology at uc davis.
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.